Literature DB >> 16330995

The rationale for metal-on-metal total hip arthroplasty.

John M Cuckler1.   

Abstract

Metal-on-metal total hip arthroplasty has the longest clinical history of any of the currently used articular couples. Long-term followup of what are now considered suboptimal designs (eg, McKee Farrar, Ring, Sivash) has produced a wealth of knowledge regarding the safety and efficacy of this articular combination. Retrieval analysis of metal-on-metal total hip arthroplasty articular couples has shown wear between 1 and 5 microns per year after initial wear-in, in comparison with 100 to 200 microns per year associated with metal-on-polyethylene wear. The constituent metal ions released through wear of the metal-on-metal total hip arthroplasty are excreted primarily in the urine; serum levels have been 3 to 5 times higher in patients who have had metal-on-metal total hip arthroplasties than in control subjects. No adverse physiologic effects have been identified in the long-term followup of patients exposed to cobalt-chromium implants. The clinical results of metal-on-metal total hip arthroplasties equal or exceed those of conventional articular couples and rarely are associated with osteolysis compared with conventional couples. Additional advantages of the metal-on-metal combination are the ability to use larger-diameter femoral heads for enhanced stability and the absence of concern over possible fracture of the articular components. The long-term experiences with metal-on-metal total hip arthroplasty make this combination of implant material the conservative choice for success.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330995     DOI: 10.1097/01.blo.0000193809.85587.f8

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  19 in total

1.  Low incidence of groin pain and early failure with large metal articulation total hip arthroplasty.

Authors:  John B Meding; Lindsey K Meding; E Michael Keating; Michael E Berend
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

2.  In vitro Wear Rate and Co Ion Release of Compositionally and Structurally Graded CoCrMo-Ti6Al4V Structures.

Authors:  Stanley Dittrick; Vamsi Krishna Balla; Susmita Bose; Amit Bandyopadhyay
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2011-05-10       Impact factor: 7.328

3.  Serum ion level after metal-on-metal THA in patients with renal failure.

Authors:  Chang Ich Hur; Taek Rim Yoon; Sang Gwon Cho; Eun Kyoo Song; Jong Keun Seon
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

4.  Metal ions activate vascular endothelial cells and increase lymphocyte chemotaxis and binding.

Authors:  James T Ninomiya; Scott A Kuzma; Timothy J Schnettler; John G Krolikowski; Janine A Struve; Dorothee Weihrauch
Journal:  J Orthop Res       Date:  2013-04-29       Impact factor: 3.494

5.  Heavy metal? Recognizing complications of metal on metal hip arthroplasty.

Authors:  Denise M Millstine; Hannah J Hakes; Anita P Mayer; Mark J Spangehl
Journal:  J Womens Health (Larchmt)       Date:  2014-06-16       Impact factor: 2.681

6.  Polyethylene oxidation in total hip arthroplasty: evolution and new advances.

Authors:  Enrique Gómez-Barrena; Francisco Medel; José Antonio Puértolas
Journal:  Open Orthop J       Date:  2009-12-24

7.  Alumina-on-alumina hip arthroplasty in patients younger than 30 years old.

Authors:  R Nizard; D Pourreyron; A Raould; D Hannouche; L Sedel
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

8.  Nanostructured diamond coatings for orthopaedic applications.

Authors:  S A Catledge; V Thomas; Y K Vohra
Journal:  Woodhead Publ Ser Biomater       Date:  2013

9.  The central role of wear debris in periprosthetic osteolysis.

Authors:  P Edward Purdue; Panagiotis Koulouvaris; Bryan J Nestor; Thomas P Sculco
Journal:  HSS J       Date:  2006-09

10.  Molecular pathology of adverse local tissue reaction caused by metal-on-metal implants defined by RNA-seq.

Authors:  Christopher G Salib; Eric A Lewallen; Christopher R Paradise; Meagan E Tibbo; Joseph X Robin; William H Trousdale; Logan M Morrey; Jason Xiao; Travis W Turner; Afton K Limberg; Anthony G Jay; Roman Thaler; Amel Dudakovic; Joaquin Sanchez-Sotelo; Mark E Morrey; Daniel J Berry; David G Lewallen; Andre J van Wijnen; Matthew P Abdel
Journal:  Genomics       Date:  2018-09-21       Impact factor: 5.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.